Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 2 1

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Carboplatin 76 Cisplatin 73 Bevacizumab 64 Radiotherapy 58 Drug Therapy 57 Capecitabine 57 Oxaliplatin 56 tislelizumab 54 toripalimab 45 Gemcitabine 45 Paclitaxel 44 Specimen Handling 42 pembrolizumab 40 anlotinib 40 sintilimab 38 Cyclophosphamide 34 130-nm albumin-bound paclitaxel 33 Injections 29 camrelizumab 26 Surgical Procedures, Operative 26 Pemetrexed 26 Magnetic Resonance Spectroscopy 26 lenvatinib 24 apatinib 23 Docetaxel 23 Biopsy 23 Etoposide 22 S 1 (combination) 21 Fluorouracil 21 Immune Checkpoint Inhibitors 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Not yet recruiting × Liquid Biopsy × Clear all

NCT07257718 2025-12-02

FUTURE

IRCCS San Raffaele

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡